InvestorsHub Logo
Followers 64
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: DewDiligence post# 454

Saturday, 09/20/2008 3:26:39 PM

Saturday, September 20, 2008 3:26:39 PM

Post# of 890
<<<"The annualized relapse rate of 0.214 seen in the Tovaxin treatment arm is on par with the lowest relapse rates observed with currently available MS treatments">>>

That ARR looks very good. It is absolutely essential that a Phase III be done.

"....on the biotech battle-field, you need some élan...."